© The Rockefeller University Press,
0021-9525/1997//935 $5.00
The Journal of Cell Biology, Volume 136, Number 4,
, 1997 935-944
Growth-inhibitory Activity and Downregulation of the Class II Tumor-suppressor Gene H-rev107 in Tumor Cell Lines and Experimental Tumors
Christine Sers*,
,
Urban Emmenegger*,
Knut Husmann*,
Katharina Bucher*,
Ann-Catherine Andres
, and
Reinhold Schäfer*,
* Division of Cancer Research, Department of Pathology, University of Zürich, CH-8091 Zürich, Switzerland;
Institute of Pathology, University Hospital Charite, D-10729 Berlin, Germany; and
Division of Clinical and Experimental Research, University of Berne, CH-3004 Berne, Switzerland
The H-rev107 gene is a new class II tumor suppressor, as defined by its reversible downregulation and growth-inhibiting capacity in HRAS transformed cell lines. Overexpression of the H-rev107 cDNA in HRAS-transformed ANR4 hepatoma cells or in FE-8 fibroblasts resulted in 75% reduction of colony formation. Cell populations of H-rev107 transfectants showed an attenuated tumor formation in nude mice. Cells explanted from tumors or maintained in cell culture for an extended period of time no longer exhibited detectable levels of the H-rev107 protein, suggesting strong selection against H-rev107 expression in vitro and in vivo. Expression of the truncated form of H-rev107 lacking the COOH-terminal membrane associated domain of 25 amino acids, had a weaker inhibitory effect on proliferation in vitro and was unable to attenuate tumor growth in nude mice. The H-rev107 mRNA is expressed in most adult rat tissues, and immunohistochemical analysis showed expression of the protein in differentiated epithelial cells of stomach, of colon and small intestine, in kidney, bladder, esophagus, and in tracheal and bronchial epithelium. H-rev107 gene transcription is downregulated in rat cell lines derived from liver, kidney, and pancreatic tumors and also in experimental mammary tumors expressing a RAS transgene. In colon carcinoma cell lines only minute amounts of protein were detectable. Thus, downregulation of H-rev107 expression may occur at the level of mRNA or protein.
Please address correspondence to Christine Sers, Institute of Pathology, Charité, Humboldt University Berlin, Schumannstr. 20/21, D-10117 Berlin, Germany. Tel.: (49) 30-2802-5181. Fax.: (49) 30-2802-8206. E-mail: chsers{at}rz.charite.hu-berlin.de

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Uyama, T., Morishita, J., Jin, X.-H., Okamoto, Y., Tsuboi, K., Ueda, N.
(2009). The tumor suppressor gene H-Rev107 functions as a novel Ca2+-independent cytosolic phospholipase A1/2 of the thiol hydrolase type. J. Lipid Res.
50: 685-693
[Abstract]
[Full Text]
-
Hummasti, S., Hong, C., Bensinger, S. J., Tontonoz, P.
(2008). HRASLS3 is a PPAR{gamma}-selective target gene that promotes adipocyte differentiation. J. Lipid Res.
49: 2535-2544
[Abstract]
[Full Text]
-
Sasaki, J., Taniguchi, K.
(2008). Aichi Virus 2A Protein Is Involved in Viral RNA Replication. J. Virol.
82: 9765-9769
[Abstract]
[Full Text]
-
Duncan, R. E., Sarkadi-Nagy, E., Jaworski, K., Ahmadian, M., Sul, H. S.
(2008). Identification and Functional Characterization of Adipose-specific Phospholipase A2 (AdPLA). J. Biol. Chem.
283: 25428-25436
[Abstract]
[Full Text]
-
Zer, C., Sachs, G., Shin, J. M.
(2007). Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-{alpha} signaling. Physiol. Genomics
31: 343-351
[Abstract]
[Full Text]
-
Nazarenko, I., Schafer, R., Sers, C.
(2007). Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells. J. Cell Sci.
120: 1393-1404
[Abstract]
[Full Text]
-
Jin, X.-H., Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., Ueda, N.
(2007). Discovery and Characterization of a Ca2+-independent Phosphatidylethanolamine N-Acyltransferase Generating the Anandamide Precursor and Its Congeners. J. Biol. Chem.
282: 3614-3623
[Abstract]
[Full Text]
-
Cozzi, S.-J., Parsons, P. G., Ogbourne, S. M., Pedley, J., Boyle, G. M.
(2006). Induction of Senescence in Diterpene Ester-Treated Melanoma Cells via Protein Kinase C-Dependent Hyperactivation of the Mitogen-Activated Protein Kinase Pathway.. Cancer Res.
66: 10083-10091
[Abstract]
[Full Text]
-
Nazarenko, I., Kristiansen, G., Fonfara, S., Guenther, R., Gieseler, C., Kemmner, W., Schafer, R., Petersen, I., Sers, C.
(2006). H-REV107-1 Stimulates Growth in Non-Small Cell Lung Carcinomas via the Activation of Mitogenic Signaling. Am. J. Pathol.
169: 1427-1439
[Abstract]
[Full Text]
-
Simmons, D. P., Peach, M. L., Friedman, J. R., Green, M. M.B., Nicklaus, M. C., De Luca, L. M.
(2006). Evidence that sequence homologous region in LRAT-like proteins possesses anti-proliferative activity and DNA binding properties: translational implications and mechanism of action. Carcinogenesis
27: 693-707
[Abstract]
[Full Text]
-
Fernandez-Vega, V., Sosnovtsev, S. V., Belliot, G., King, A. D., Mitra, T., Gorbalenya, A., Green, K. Y.
(2004). Norwalk Virus N-Terminal Nonstructural Protein Is Associated with Disassembly of the Golgi Complex in Transfected Cells. J. Virol.
78: 4827-4837
[Abstract]
[Full Text]
-
Bharadwaj, S., Hitchcock-DeGregori, S., Thorburn, A., Prasad, G. L.
(2004). N Terminus Is Essential for Tropomyosin Functions: N-TERMINAL MODIFICATION DISRUPTS STRESS FIBER ORGANIZATION AND ABOLISHES ANTI-ONCOGENIC EFFECTS OF TROPOMYOSIN-1. J. Biol. Chem.
279: 14039-14048
[Abstract]
[Full Text]
-
Sturniolo, M. T., Dashti, S. R., Deucher, A., Rorke, E. A., Broome, A.-M., Chandraratna, R. A. S., Keepers, T., Eckert, R. L.
(2003). A Novel Tumor Suppressor Protein Promotes Keratinocyte Terminal Differentiation via Activation of Type I Transglutaminase. J. Biol. Chem.
278: 48066-48073
[Abstract]
[Full Text]
-
Yadetie, F., Laegreid, A., Bakke, I., Kusnierczyk, W., Komorowski, J., Waldum, H. L., Sandvik, A. K.
(2003). Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-{alpha} agonist ciprofibrate. Physiol. Genomics
15: 9-19
[Abstract]
[Full Text]
-
Chatterjee, M., Honemann, D., Lentzsch, S., Bommert, K., Sers, C., Herrmann, P., Mathas, S., Dorken, B., Bargou, R. C.
(2002). In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway. Blood
100: 3311-3318
[Abstract]
[Full Text]
-
Roder, K., Latasa, M.-J., Sul, H. S.
(2002). Silencing of the Mouse H-rev107 Gene Encoding a Class II Tumor Suppressor by CpG Methylation. J. Biol. Chem.
277: 30543-30550
[Abstract]
[Full Text]
-
Zeng, Z.-Z., Higashi, S., Kitayama, W., Denda, A., Yan, Y., Matsuo, K., Konishi, Y., Hiai, H., Higashi, K.
(2000). Genetic Resistance to Chemical Carcinogen-induced Preneoplastic Hepatic Lesions in DRH Strain Rats. Cancer Res.
60: 2876-2881
[Abstract]
[Full Text]
-
Hughes, P. J., Stanway, G.
(2000). The 2A proteins of three diverse picornaviruses are related to each other and to the H-rev107 family of proteins involved in the control of cell proliferation. J. Gen. Virol.
81: 201-207
[Abstract]
[Full Text]
-
DiSepio, D., Ghosn, C., Eckert, R. L., Deucher, A., Robinson, N., Duvic, M., Chandraratna, R. A. S., Nagpal, S.
(1998). Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc. Natl. Acad. Sci. USA
95: 14811-14815
[Abstract]
[Full Text]
-
Andreu, T., Beckers, T., Thoenes, E., Hilgard, P., von Melchner, H.
(1998). Gene Trapping Identifies Inhibitors of Oncogenic Transformation. THE TISSUE INHIBITOR OF METALLOPROTEINASES-3 (TIMP3) AND COLLAGEN TYPE I alpha 2 (COL1A2) ARE EPIDERMAL GROWTH FACTOR-REGULATED GROWTH REPRESSORS. J. Biol. Chem.
273: 13848-13854
[Abstract]
[Full Text]